Multiple Sclerosis: A Guide To Pharmacologic Treatment by Daniel OntanedaMultiple Sclerosis: A Guide To Pharmacologic Treatment by Daniel Ontaneda

Multiple Sclerosis: A Guide To Pharmacologic Treatment

byDaniel Ontaneda

Paperback | October 1, 2013

Pricing and Purchase Info

$25.36 online 
$25.95 list price
Earn 127 plum® points

Prices and offers may vary in store


In stock online

Ships free on orders over $25

Not available in stores


The arena of multiple sclerosis (MS) treatment has changed substantially over the past 20 years. Now nine different agents are approved for use in MS with several different routes of administration, safety characteristics and efficacy profiles.

For the clinician and patient the availability of agents means greater flexibility and chances of disease control. However the expansion of options has also made the treatment of MS an increasingly complex field.

This book is intended to help the general neurologist, internist and pharmaceutical industry agent to quickly become familiar with the current and future options for treating relapsing forms of MS.

Dr. Daniel Ontaneda is an Assistant Professor of Medicine and Neurology at The Cleveland Clinic Lerner College of Medicine of Case Western Reserve University. He received his medical degree from The Pontificia Universidad Católica del Ecuador and holds a Master of Science in Clinical Research from Case Western Reserve University. He co...
Title:Multiple Sclerosis: A Guide To Pharmacologic TreatmentFormat:PaperbackDimensions:150 pages, 6.7 × 4.73 × 0.68 inPublished:October 1, 2013Publisher:Seed Medical PublishersLanguage:English

The following ISBNs are associated with this title:

ISBN - 10:889741947X

ISBN - 13:9788897419471

Look for similar items by category:


Table of Contents

IntroductionScopeOverview of multiple sclerosisDisease modifying agents for multiple sclerosisInterferon for MSGlatiramer acetate for MSMitoxantrone for MSNatalizumab for MSFingolimod for MSTeriflunomide for MSDimethyl fumarate for MSTreatment of relapsesDefining relapsesTreatment of MS relapsesEmerging therapies for multiple sclerosisLaquinimod for MSAlemtuzumab for MSDaclizumab for MSOcrelizumab and rituximab for MS